Maryland Insurance

Baltimore, MD - The Insurance Commissioner Ralph S. Tyler and Attorney General Douglas Gansler announced today that Maryland is the first State to a comprehensive plan to regulate the activities of pharmacy benefit managers.

The plan, in a number of bills that meeting, with the Registry of the State, consumers and the information necessary business practices.

Pharmacy Benefit Manager (PBMs) to manage prescription benefits for health insurance and employers. To do so, PBMs contract with pharmacies and pharmaceutical manufacturers, and interact with consumers and providers of medical services on behalf of health insurance and employers.

“In health, there are rules about everything,” said Commissioner Tyler. “This comprehensive plan to regulate these agencies to manage that many of our rules ensures that consumers and the marketplace of health systems will be treated fairly and with the situation, to take decisions.” In recent years, the prosecutor general of the Office has negotiated settlements with the pharmacy benefits manager Medco Health Solutions, Inc. and Mark Care Rx, LLC, which implies the need for tighter control of this part of the system health care.

These colonies focused on the protection of consumers against the power is turned toward PBMs cheaper medicines to higher costs of prescription drugs without medical benefits. The settlements the PBMs to offer medical insurers and employers with financial information when awarding contracts. The legislation of the General Assembly focuses on these areas, creating conditions for all PBMs similar in both colonies. In addition, the legislation regulates other aspects of the PBM business.

“The passage of these accounts recognizes the important issues in the colonies, my office,” said Attorney General Gansler. “It is essential that this regime has not resolved the delivery of business services for consumers and Maryland, the Health market.” While other countries have regulated some aspects of the PBM, the passage of these bills, provides the first comprehensive plan to regulate PBMs.

First, HB 149 / SB722 be to require that agencies PBM in the Maryland register with the Maryland Insurance Administration (MIA). This allows you to follow these MIA organizations and some assessments of their behaviour on the business market practices.

Next HB 343 / SB 723 protects consumers by information when the PBM is a patient to change the recipe - as a therapeutic exchange. Given that PBMs have signed contracts with several manufacturers of drugs, PBM perhaps preferable that patients of a mark on another medication brand name drugs in the same class. During a health care provider must approve an exchange therapeutic, this law is subject to the PBM (a pharmacist) to disclose certain information relating to the exchange therapeutic to both the providers of access to health and consumers, including health and financial implications for the consumer.

The accounts of the address of practices between the PBM and health insurance company or employer. HB 580/SB 720 stipulates that PBMs to ensure that individuals for findings on drugs in the PBM formula on the collection of lists of identification and some conflicts in the interest of the PBM. HB120 / SB724 provides that the PBMs are required to provide certain information on rebates and other payments, manufacturers of medicines for health insurance and employers in the process of negotiating contracts.

Finally, pharmacists and pharmacies were, insofar as certain protective mechanisms with the adoption of HB-257 / SB725. This law permits the disclosure of certain information, such as taxes, pharmacies and pharmacists when awarding contracts with PBMs. It lays down specific rules with regard to examinations by pharmacies and PBMs procedures to resolve inconsistencies. The law also requires PBMs have an internal appeal procedure for pharmacies, if it is a denial of payment.

Insurance Commissioner and the Attorney General very much appreciates the efforts of the health facility and Heads of Government Operations Committee of the Senate Finance and other members of the General Assembly in championing this package of bills to the creation of a strong regulatory system and contain mechanisms for the protection of consumers.